<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04152733</url>
  </required_header>
  <id_info>
    <org_study_id>H1910-038-1068</org_study_id>
    <nct_id>NCT04152733</nct_id>
  </id_info>
  <brief_title>Effect of High Flow Nasal Cannula on Oxygenation During Urodynamic Study in Pediatric Population</brief_title>
  <official_title>Effect of High Flow Nasal Cannula on Oxygenation During Urodynamic Study in Pediatric Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of high flow nasal cannula for prevention of hypoxia during deep
      sedation in pediatric population
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of desaturation</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
    <description>Incidence of peripheral pulse oximeter value lower than 95%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimum pulse oximeter value</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of peripheral pulse oximeter value lower than 90%</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of changes in oxygen flow (control group) or FiO2 (HF group)</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percutaneous CO2 value</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen reserve index value</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of manual ventilation</measure>
    <time_frame>During deep sedation (during approximately 1 hour after propofol infusion)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Desaturation</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Children in the control group receive oxygen via conventional nasal cannula during deep sedation. Oxygen flow is determined to set the fraction of inspired oxygen of 50%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow (HF) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children in the HF group receive oxygen via high flow nasal cannula during deep sedation. Fraction of inspired oxygen is set to 50%.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High flow nasal cannula</intervention_name>
    <description>Oxygen is supplied via high flow nasal cannula. Heated air (2L/kg/min) is administered using Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand).</description>
    <arm_group_label>High flow (HF) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged &lt;7 years

          -  ASA class I, II

        Exclusion Criteria:

          -  Respiratory disease

          -  Pneumothorax

          -  Increased ICP

          -  Nasal bleeding

          -  Previous airway surgery

          -  Trauma

          -  Pulmonary hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Tae Kim, MD, PhD</last_name>
    <phone>82-2-2072-3661</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, Pf.</last_name>
      <phone>+82-2-2072-3295</phone>
      <email>jintae73@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>November 3, 2019</study_first_submitted>
  <study_first_submitted_qc>November 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2019</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

